About This Course

An interactive course for healthcare providers, designed to introduce you to the development and use of targeted therapeutics as later-line therapy in patients with cholangiocarcinoma.

This course should take you 30-60 minutes to complete.

This course has a 2-year expiry date of 07 September 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.

Learning Outcomes

By the end of this course, you should be able to:

  • define cholangiocarcinoma and describe the burden of disease.

  • list at least 3 actionable molecular alterations currently identified in cholangiocarcinoma..

  • explain to patients the value of molecular testing for their cancer.

  • summarize the outcomes of targeted therapies in cholangiocarcinoma.

Expert Faculty

This course has been made in close collaboration with:

Course curriculum

    1. Welcome to the Course

    1. Introduction to Precourse Quiz

    2. Precourse Quiz

    1. What is Cholangiocarcinoma?

    1. Biomarkers and Targets

    1. Outcomes of Targeted Interventions

    1. Introduction to Final Quiz

    2. Final Quiz

    1. Conclusions and Take-Home Messages

    2. Course Feedback Survey

About this course

  • Free
  • 10 lessons
  • 0 hours of video content

This course has been funded with an educational grant from Taiho Oncology, Inc.

You can also find this course on the Oncology Learning Hub, sponsored by Taiho Oncology: https://oncologylearninghub.org/